TET (Ten-eleven translocation) family proteins: structure, biological functions and applications

X Zhang, Y Zhang, C Wang, X Wang - Signal Transduction and …, 2023 - nature.com
Ten-eleven translocation (TET) family proteins (TETs), specifically, TET1, TET2 and TET3,
can modify DNA by oxidizing 5-methylcytosine (5mC) iteratively to yield 5 …

Berberine: a review of its pharmacokinetics properties and therapeutic potentials in diverse vascular diseases

X Ai, P Yu, L Peng, L Luo, J Liu, S Li, X Lai… - Frontiers in …, 2021 - frontiersin.org
Traditional Chinese medicine plays a significant role in the treatment of various diseases
and has attracted increasing attention for clinical applications. Vascular diseases affecting …

Role of EZH2-mediated epigenetic modification on vascular smooth muscle in cardiovascular diseases: a mini-review

H Luo, Y Li, H Song, K Zhao, W Li, H Hong… - Frontiers in …, 2024 - frontiersin.org
Vascular smooth muscle cells (VSMCs) are integral to the pathophysiology of cardiovascular
diseases (CVDs). Enhancer of zeste homolog 2 (EZH2), a histone methyltransferase, plays a …

Hypoxia-induced signaling in the cardiovascular system: pathogenesis and therapeutic targets

Y Zhao, W Xiong, C Li, R Zhao, H Lu, S Song… - … and Targeted Therapy, 2023 - nature.com
Hypoxia, characterized by reduced oxygen concentration, is a significant stressor that affects
the survival of aerobic species and plays a prominent role in cardiovascular diseases. From …

Association Between Circulating CD4+ T Cell Methylation Signatures of Network-Oriented SOCS3 Gene and Hemodynamics in Patients Suffering Pulmonary Arterial …

G Benincasa, BA Maron, O Affinito, M D'Alto… - Journal of …, 2023 - Springer
Pathogenic DNA methylation changes may be involved in pulmonary arterial hypertension
(PAH) onset and its progression, but there is no data on potential associations with patient …

Unraveling the epigenetic landscape of pulmonary arterial hypertension: implications for personalized medicine development

J Dave, V Jagana, R Janostiak, M Bisserier - Journal of Translational …, 2023 - Springer
Pulmonary arterial hypertension (PAH) is a multifactorial disease associated with the
remodeling of pulmonary blood vessels. If left unaddressed, PAH can lead to right heart …

Pulmonary vascular remodeling in pulmonary hypertension

Z Jia, S Wang, H Yan, Y Cao, X Zhang, L Wang… - Journal of Personalized …, 2023 - mdpi.com
Pulmonary vascular remodeling is the critical structural alteration and pathological feature in
pulmonary hypertension (PH) and involves changes in the intima, media and adventitia …

Rescuing lung development through embryonic inhibition of histone acetylation

G Stokes, Z Li, N Talaba, W Genthe, MB Brix… - Science Translational …, 2024 - science.org
A major barrier to the impact of genomic diagnosis in patients with congenital malformations
is the lack of understanding regarding how sequence variants contribute to disease …

Epigenetic regulation of programmed cell death in hypoxia-induced pulmonary arterial hypertension

Y Jiang, S Song, J Liu, L Zhang, X Guo, J Lu… - Frontiers in …, 2023 - frontiersin.org
Pulmonary arterial hypertension (PAH) is a severe progressive disease that may cause early
right ventricular failure and eventual cardiac failure. The pathogenesis of PAH involves …

Therapeutic approaches for treating pulmonary arterial hypertension by correcting imbalanced TGF-β superfamily signaling

P Andre, SR Joshi, SD Briscoe, MJ Alexander… - Frontiers in …, 2022 - frontiersin.org
Pulmonary arterial hypertension (PAH) is a rare disease characterized by high blood
pressure in the pulmonary circulation driven by pathological remodeling of distal pulmonary …